Benzene is classified as a Group 1 carcinogen by the IARC, meaning it is known to cause cancer in humans—specifically leukemia. Recently, stability testing by independent laboratories has revealed that Benzoyl Peroxide (BPO) products, commonly used for acne treatment, can degrade into benzene under certain temperature conditions.
This discovery has triggered a wave of concern regarding product safety, manufacturing stability, and consumer exposure.
The Mechanism of Degradation: Unlike contamination cases where benzene is an impurity introduced during manufacturing (as seen in some sunscreens and dry shampoos), the issue with BPO appears to be inherent to the chemical structure of the product itself. When exposed to heat (e.g., a hot bathroom or delivery truck), the BPO molecule breaks down to form benzene gas.
Implications for Litigation:
- Exposure Duration: Calculating the potential “dose” a consumer received over years of product use.
- Risk Assessment: Determining if the exposure levels exceeded FDA permissive limits (2 ppm) and if those levels are sufficient to cause the specific type of cancer claimed by a plaintiff.
As these mass tort cases evolve, scientific analysis of shelf-life stability and degradation rates will be the cornerstone of the legal arguments.